Cargando…

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis

Galectin-3 regulates numerous biological processes in the gut. We investigated molecular mechanisms responsible for the Galectin-3-dependent regulation of colon inflammation and evaluated whether Galectin-3 may be used as biomarker for monitoring the progression of ulcerative colitis (UC). The diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volarevic, Vladislav, Zdravkovic, Natasa, Harrell, Carl Randall, Arsenijevic, Nebojsa, Fellabaum, Crissy, Djonov, Valentin, Lukic, Miodrag L., Simovic Markovic, Bojana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678202/ https://www.ncbi.nlm.nih.gov/pubmed/31336879 http://dx.doi.org/10.3390/cells8070709

Ejemplares similares

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Molecular mechanisms underlying therapeutic potential of pericytes
por: Harrell, C. Randall, et al.
Publicado: (2018)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma
por: Harrell, C. Randall, et al.
Publicado: (2019)

Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression
por: Jovanovic, Marina, et al.
Publicado: (2019)

Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
por: Simovic Markovic, Bojana, et al.
Publicado: (2017)

Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases
por: Gazdic, Marina, et al.
Publicado: (2017)

Stem Cells Therapy for Spinal Cord Injury
por: Gazdic, Marina, et al.
Publicado: (2018)

Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response
por: Gazdic, Marina, et al.
Publicado: (2017)

Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis
por: Simovic Markovic, Bojana, et al.
Publicado: (2016)

Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin
por: Harrell, C. Randall, et al.
Publicado: (2018)

The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration
por: Miloradovic, Dragana, et al.
Publicado: (2020)

Ethical and Safety Issues of Stem Cell-Based Therapy
por: Volarevic, Vladislav, et al.
Publicado: (2018)

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
por: Harrell, C. Randall, et al.
Publicado: (2019)

Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis
por: Arsenijevic, Aleksandar, et al.
Publicado: (2017)

Galectin-3 Deficiency Facilitates TNF-α-Dependent Hepatocyte Death and Liver Inflammation in MCMV Infection
por: Stojanovic, Bojana, et al.
Publicado: (2019)

Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens
por: Arsenijevic, Aleksandar, et al.
Publicado: (2016)

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
por: Volarevic, Vladislav, et al.
Publicado: (2011)

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016)

Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
por: Bracho-Sanchez, Evelyn, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development
por: Arsenijevic, Aleksandar, et al.
Publicado: (2020)

Anemia of inflammation in patients with colorectal cancer: Correlation with interleukin-1, interleukin-33 and galectin-1
por: Jocić, Miodrag, et al.
Publicado: (2022)

Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets
por: Pejnovic, Nada N, et al.
Publicado: (2013)

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020)

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma
por: Milosavljevic, Milos Z., et al.
Publicado: (2016)

IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
por: Borovcanin, Milica M., et al.
Publicado: (2018)

Galectin-3 Deficiency Accelerates High-Fat Diet–Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
por: Pejnovic, Nada N., et al.
Publicado: (2013)

Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
por: Rudjord-Levann, Asha M., et al.
Publicado: (2023)

Intra-Articular Delivery of an Indoleamine 2,3-Dioxygenase Galectin-3 Fusion Protein for Osteoarthritis Treatment in Male Lewis Rats
por: Partain, Brittany D., et al.
Publicado: (2023)

Intra-articular delivery of an indoleamine 2,3-dioxygenase galectin-3 fusion protein for osteoarthritis treatment in male Lewis rats
por: Partain, Brittany D., et al.
Publicado: (2023)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host–Pathogen Interactions
por: Stojanovic, Bojana S., et al.
Publicado: (2023)

Targeting the indoleamine 2,3-dioxygenase pathway in cancer
por: Moon, Yong Wha, et al.
Publicado: (2015)

The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents
por: Pantic, Jelena M., et al.
Publicado: (2017)

The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8nml7goj235omm2us580uanmi3